Aurélien Chendjou Kamela | Hématologie | Best Researcher Award

Posted on by ScienceFather

Mr. Aurélien Chendjou Kamela | Hématologie | Best Researcher Award

Technicien Classe B at , CISSS Chaudière-appalaches, Canada

A seasoned health sciences professional, this individual has over 5 years of experience in research and project management. With a strong background in clinical planning and support, they have gained a solid reputation in hematology, particularly in sickle cell and hemophilia research. Their expertise has been instrumental in implementing screening and awareness campaigns across Cameroon, and they have contributed significantly to scientific publications and research protocols. Currently a lab technician at CISSS Chaudière-Appalaches, they continue to build on their experience while advancing in functional genomics at Université Laval.

Publication Profile

orcid

Education 🎓

They began their academic journey with a BSc in Biology of Animal Organisms (2012–2015) from Université de Yaoundé I. To further specialize, they pursued a Master’s in Medical Hematology (2020–2022) from the same university, which laid the foundation for their deep focus on blood disorders. Eager to stay at the forefront of scientific advancements, they are now expanding their expertise through a Microprogram in Functional Genomics (2023–2024) at Université Laval. This diverse educational path equips them with both theoretical knowledge and practical skills essential for their research roles in health sciences.

Experience 🔬

They currently work as a Lab Technician (2024–present) at CISSS Chaudière-Appalaches, where they manage specimen preparation, inventory, and laboratory data. Prior to this, they were the Project Manager for Screening/Diagnosis (2021–2023) at GEDREPACAM, leading neonatal screening and public health initiatives for sickle cell disease. Their role as a Research Student (2017–2022) at the Hemophilia Treatment Center in Yaoundé honed their ability to manage research projects independently. They’ve also coordinated biological diagnostics at IECD (2021) and handled data entry for the same organization (2019–2021). Their diverse professional background reflects a balance of research, clinical work, and project management.

Awards and Honors 🏅

Their research has earned recognition through multiple grants from the World Federation of Hemophilia. In 2022, they secured funding for their project evaluating the quality of life of hemophilia patients under prophylactic treatment in Cameroon. They were also the Principal Investigator for the Hemophilia Treatment Center financing program (2021 and 2022 editions), backed by the same federation. These awards underscore their dedication to improving the healthcare landscape for hemophilia patients, particularly in resource-limited settings. Their ability to secure funding reflects their expertise in both research and project execution, enhancing their reputation in the field.

Research Focus🔬 

Their research primarily centers on blood disorders like hemophilia and sickle cell disease. They have been involved in evaluating quality-of-life measures for hemophilia patients, especially those under prophylactic treatment in Cameroon. They are also skilled in managing and analyzing clinical samples, devising new diagnostic protocols, and publishing scientific findings. Their research contributions extend to the screening and prevention of sickle cell disease, where they have led initiatives in public health campaigns. This individual also plays a key role in educating and training future researchers, ensuring that their expertise is passed on to the next generation

Publication  Top Notes

Biological Abnormalities of Hemostasis in Patients with Epistaxis or Menorrhagia in Yaoundé, Cameroon

Conclusion

The candidate is well-suited for the Research for Best Researcher Award due to their strong educational background, significant contributions to hematology and sickle cell disease research, and proven project management skills. Their ability to secure international funding, publish research, and contribute to public health initiatives reflects their commitment to advancing the medical sciences. With a focus on expanding their research portfolio and further enhancing international collaboration, they have the potential to achieve even greater success in the field of health science research.